newsfilter
← Latest News
Business Wire·

Pear Therapeutics to Participate in Citi's BioTech C-Suite Virtual Fireside Chat Series

Pear Therapeutics, Inc. (NASDAQ:PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will participate in Citi's